<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/0A724775-C91F-4C29-9229-45F21DC8685C" ns1:id="0A724775-C91F-4C29-9229-45F21DC8685C"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/ED9FBB4C-6903-455D-AD5B-7AC65A39BE9E" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/63998F49-4D68-4D12-932C-C0725922DD6B" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/63998F49-4D68-4D12-932C-C0725922DD6B" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2020-05-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/392761A0-9CB6-4789-9A94-5F1F91B5E556" ns1:rel="FUND" ns1:start="2019-03-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">105034</ns2:identifier></ns2:identifiers><ns2:title>Use of bioimpedance and machine learning to predict transplant organ viability</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>This project addresses a critical health problem of global significance - the shortage of organs for transplantation. For the better part of four decades, human organ supply has not kept pace with demand.

Currently only a small fraction of organs are retrieved from donation after circulatory death (DCD) even though this is the most common type of death. It is quoted that more than 60% of the hearts and lungs must be discarded annually.

New technologies are desperately required to expand the much needed pool of transplant organs.

We have identified a technology solution to assess and validate a patient's tissue (organ) viability and integrity.

Our approach is disruptive and will:

(1) afford quality organ harvesting;

(2) expand the pool of 'much-needed' organs among donation from circulatory death;

(3) reduce organ discard;

(4) reduce financial impact upon healthcare systems;

(5) enhance outcomes for recipient patients; and

(6) facilitate research in an area that can save tens of thousands of lives annually.</ns2:abstractText></ns2:project>